TCV Trust & Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.1M Sell
22,565
-509
-2% -$601K 2.02% 13
2026
Q2
$27.7M Buy
23,074
+49
+0.2% +$50.1K 2.1% 11
2026
Q1
$21.2M Sell
23,025
-481
-2% -$488K 1.77% 14
2025
Q4
$25.3M Buy
23,506
+226
+1% +$216K 2.04% 10
2025
Q3
$17.8M Sell
23,280
-55
-0.2% -$40.9K 1.49% 17
2025
Q2
$18.2M Sell
23,335
-682
-3% -$530K 1.59% 15
2025
Q1
$19.8M Buy
24,017
+19
+0.1% +$15.8K 1.84% 12
2024
Q4
$18.5M Buy
23,998
+236
+1% +$195K 1.71% 14
2024
Q3
$21.1M Sell
23,762
-759
-3% -$682K 1.89% 10
2024
Q2
$22.2M Sell
24,521
-253
-1% -$202K 2.12% 9
2024
Q1
$19.3M Sell
24,774
-474
-2% -$337K 1.85% 13
2023
Q4
$14.7M Sell
25,248
-178
-0.7% -$104K 1.48% 21
2023
Q3
$13.7M Buy
25,426
+778
+3% +$401K 1.51% 23
2023
Q2
$11.6M Buy
24,648
+491
+2% +$206K 1.23% 32
2023
Q1
$8.3M Buy
24,157
+22,734
+1,598% +$7.67M 0.92% 39
2022
Q4
$521K Sell
1,423
-100
-7% -$35.5K 0.06% 137
2022
Q3
$492K Sell
1,523
-92
-6% -$29.1K 0.06% 132
2022
Q2
$524K Sell
1,615
-80
-5% -$24K 0.06% 132
2022
Q1
$485K Sell
1,695
-2,400
-59% -$618K 0.05% 142
2021
Q4
$1.13M Hold
4,095
– – 0.11% 109
2021
Q3
$946K Buy
4,095
+2,445
+148% +$603K 0.1% 109
2021
Q2
$379K Hold
1,650
– – 0.04% 153
2021
Q1
$308K Sell
1,650
-75
-4% -$14.7K 0.04% 155
2020
Q4
$291K Hold
1,725
– – 0.04% 156
2020
Q3
$256K Sell
1,725
-15
-0.9% -$2.32K 0.03% 160
2020
Q2
$286K Sell
1,740
-60
-3% -$9.21K 0.04% 151
2020
Q1
$250K Sell
1,800
-875
-33% -$120K 0.04% 146
2019
Q4
$351K Sell
2,675
-100
-4% -$11.6K 0.04% 148
2019
Q3
$311K Hold
2,775
– – 0.04% 160
2019
Q2
$307K Sell
2,775
-50
-2% -$5.89K 0.04% 166
2019
Q1
$367K Sell
2,825
-230
-8% -$28K 0.05% 157
2018
Q4
$354K Sell
3,055
-45
-1% -$5.03K 0.05% 156
2018
Q3
$333K Hold
3,100
– – 0.04% 166
2018
Q2
$265K Buy
+3,100
New +$255K 0.04% 181
2018
Q1
– Sell
-2,610
Closed -$220K – 204
2017
Q4
$220K Sell
2,610
-475
-15% -$40.4K 0.03% 186
2017
Q3
$264K Buy
+3,085
New +$253K 0.04% 167
2016
Q3
– Sell
-2,625
Closed -$207K – 167
2016
Q2
$207K Buy
+2,625
New +$198K 0.04% 160

Other funds holding LLY

TCV Trust & Wealth Management's LLY Position: Q3 2026 in Review

TCV Trust & Wealth Management reduced its Eli Lilly (LLY) stake by 2.2% in Q3 2026, selling an estimated $601K and leaving 22,565 shares worth $26.1M. The position accounts for 2.02% of the portfolio, ranked #13.

TCV Trust & Wealth Management first reported a position in LLY in Q2 2016 and has held it in 37 quarters since. The position peaked at $27.7M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • TCV Trust & Wealth Management held 22,565 shares of Eli Lilly worth $26.1M as of Q3 2026.
  • TCV Trust & Wealth Management sold 509 Eli Lilly shares in Q3 2026, an estimated $601K.
  • Eli Lilly made up 2.02% of TCV Trust & Wealth Management's portfolio in Q3 2026, its #13 holding.
  • TCV Trust & Wealth Management first reported a position in Eli Lilly in Q2 2016 and has held it in 37 quarters since.
  • TCV Trust & Wealth Management's Eli Lilly position peaked at $27.7M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.